Alberto
Cordero
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (40)
2024
-
Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction
American Journal of Cardiology, Vol. 211, pp. 9-16
-
Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97
2023
-
Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials
The American journal of cardiology, Vol. 205, pp. 321-324
-
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events
Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611
2022
-
Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
Journal of Clinical Medicine, Vol. 11, Núm. 11
-
Current trends on antithrombotic therapy
REC: CardioClinics
-
Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials
American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575
2021
-
Acute coronary syndrome in the older patient
Journal of Clinical Medicine, Vol. 10, Núm. 18
-
Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772
-
Direct oral anticoagulants versus warfarin in octogenarians with nonvalvular atrial fibrillation: A systematic review and meta‐analysis
Journal of Clinical Medicine, Vol. 10, Núm. 22
-
Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS
REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
-
Mortality associated with cardiovascular disease in patients with COVID-19
REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38
-
Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score
Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 3, pp. E342-E350
-
Predictive value of pro-bnp for heart failure readmission after an acute coronary syndrome
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Selection of the best of 2020 in geriatric cardiology
REC: CardioClinics, Vol. 56, pp. 3-8
-
Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain
REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178
-
Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction
Journal of Cardiac Failure, Vol. 27, Núm. 4, pp. 427-434
2020
-
CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction
American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4